Anhui Fengyuan Pharmaceutical Co., Ltd.
000153.SZ · SHZ
Market closed5.54-0.250000 (-4.32%)
Key statistics
Previous close5.79
Open5.65
Day high5.83
Day low5.54
52-week high8.08
52-week low4.95
Market cap2.57B
Volume8.97M
Average volume8.63M
P/E ratio18.81
Forward P/E—
EPS0.29
Dividend yield+1.81%
Market context
Why it moved
In the absence of specific company news for 000153.SZ, the stock's sharp decline likely reflects broader market selling pressure and negative investor sentiment, potentially compounded by rising fuel costs and geopolitical instability in the Middle East weighing on industrial and energy-linked equities in the Chinese market.
What is happening
Recent company-specific developments and publisher coverage.
finance.biggo.com · July 11, 2026Fengyuan Pharmaceutical's Control Set to Change: Concerted Parties to Exit in approximately $103.6 Million Deal, Bengbu State Capital Likely Buyer富途牛牛 · July 10, 2026Fengyuan Pharmaceutical's controlling stake may change hands as Bengbu Investment Group plans to take control with a RMB 7 billion investment | Quick Read Announcementwww.marketscreener.com · July 9, 2026BengBu Investment Group Co.,Ltd entered into a Share Transfer Intent Agreement to acquire 23.52% stake in Anhui Fengyuan Pharmaceutical Co., Ltd. from Anhui Bangbu Tushan Pharmaceutical Factory, Anhui Maanshan Biochemical Pharmaceutical Factormarketscreener.com · April 28, 2026Anhui Fengyuan Pharmaceutical Co., Ltd. announces Annual dividend, payable on June 18, 2026 Mt Newswire · May 13, 2026Fengyuan Pharma's Unit Gets Nod for Marketing of Vonoprazan Fumarate Mt Newswire · May 8, 2026Anhui Fengyuan Pharmaceutical Gets China Regulatory Approval for Pediatric Constipation Drug